1-5 of 5
Meifang Li
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Venetoclax Plus Azacitadine for Middle Aged and Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia: Interim Analysis of a Prospective, Multicenter, Single-Arm, Phase 2 Trial

Free
Rui Huang, Xiaonan Lin, Yuming Zhang, YongZhong Su, Caixia Wang, Jihao Zhou, Zhenqian Huang, Jinxiong Huang, Xiong Zhang, Ying Zhao, Yuexiong Liang, Xiaotao Wang, Xuekui Gu, Honghua He, Yaling Zheng, Sanfang Tu, FeiHeng Chen, Shaoze Lin, Yaya Wang, Ying Dong, Pengcheng Huang, Zenghui Liu, Xiaoli Xu, Zhao Liang, Xuan Zhou, Meifang Li, Man Luo, Ming Wu, Fang Jiang, Qin Liu, Hui Zeng, Chaoyang Song, Yuhua Li
Journal: Blood
Blood (2023) 142 (Supplement 1): 4263.
https://doi.org/10.1182/blood-2023-177568
Published: 2023
Journal Articles

Efficacy and Safety of Chimeric Antigen Receptor T Cells Therapy Strategy with Dual Targeting of CD19 and CD70 to Treat Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Free
Sanfang Tu, Lijuan Zhou, Rui Huang, Xuan Zhou, Jilong Yang, Meifang Li, Bo Jin, Langqi Wang, Yaqi Zhuo, Huifang Chen, Lung-Ji Chang, Yuhua Li
Journal: Blood
Blood (2023) 142 (Supplement 1): 3492.
https://doi.org/10.1182/blood-2023-186888
Published: 2023
Journal Articles

Efficacy and Safety of Chimeric Antigen Receptor T Cells Therapy Strategy That Dual Targeting CD19 and CD22 to Treat Relapsed/Refractory Acute Lymphoblastic Leukemia in Adults

Free
Sanfang Tu, Lijuan Zhou, Rui Huang, Xuan Zhou, Jilong Yang, Meifang Li, Bo Jin, Langqi Wang, Yaqi Zhuo, Huifang Chen, Lung-Ji Chang, Yuhua Li
Journal: Blood
Blood (2023) 142 (Supplement 1): 6884.
https://doi.org/10.1182/blood-2023-186622
Published: 2023
Journal Articles

A Novel Chimeric Antigen Receptor T Cells Therapy Strategy That Dual Targeting CD19 and CD123 to Treat Relapsed Acute Lymphoblastic Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation

Free
Sanfang Tu, MD PhD, Lan Deng, MD PhD, Rui Huang, MD PhD, Xuan Zhou, MD, Jilong Yang, MD, Weijun Zhou, MD PhD, Meifang Li, MD PhD, Chunyan Yue, MD, Shaojie Wu, MD PhD, Zhenling Guo, Lung-Ji Chang, PhD, Yuhua Li, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4015.
https://doi.org/10.1182/blood-2018-99-118526
Published: 2018
Journal Articles

Therapy of 4s Chimeric Antigen Receptor T Cells Achieves Long-Term Disease-Free Survival with No Severe CRS or Cres in Patients with Relapsed and Refractory Acute Lymphoblastic Leukemia

Free
Sanfang Tu, MD PhD, Rui Huang, MD PhD, Lan Deng, MD PhD, Xuan Zhou, MD, Yanjie He, MD PhD, Weijun Zhou, MD PhD, Jilong Yang, MD, Chunyan Yue, MD, Anqin Wu, Meifang Li, MD PhD, Zhenling Guo, Lung-Ji Chang, PhD, Yuhua Li, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2696.
https://doi.org/10.1182/blood-2018-99-118928
Published: 2018